m+Medelevator.RU
← Поиск публикаций
Science advances · 2026

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Wang Haichao, Mennea Paulius D, McAndrew Grainne, Sonmezler Ozge, Shcherbo Dmitry S, Ditter Emma-Jane, Jensen Sarah Østrup, Buma Alessandra I G, Smith Christopher G, Cheng Zhao, Harris Clare, Cutts Rosalind J, Hrebien Sarah, Crosbie Philip A J, Corrie Pippa G, van den Heuvel Michel M, Roshan Amit, McCaughan Frank, Rintoul Robert C, Markowetz Florian, Kaplan Tommy, Cooper Wendy N, Zhao Hui, Rosenfeld Nitzan

Аннотация

Cell-free DNA (cfDNA) in body fluids enables noninvasive cancer detection. Multifeature artificial intelligence (AI) can improve sensitivity by integrating diverse biomarkers when cancer signals are sparse. Tumor-informed assays that rely on mutations have limited practicality for early cancer detection. Emerging fragmentomic and epigenetic features underpin tumor-naive approaches to screening for individuals with low tumor burden. Here, we designed UNITE-a universal cfDNA feature ensemble framework that provides scalable cancer detection methods based on "genomic bin-fragment length" matrices derived from shallow whole-genome sequencing (sWGS) data at 0.1× depth. Using sWGS data from 2063 plasma samples (631 controls and 1432 cases from 26 cancer types), we systematically evaluated both XGBoost (UNITE-XGB) and convolutional neural networks (UNITE-CNN) across multiple feature spaces and cancer stages. In stage I-II cancer, UNITE-XGB and UNITE-CNN achieved 31 and 21% sensitivity, respectively, at 95% specificity. These findings provide roadmaps for developing multifeature AI beyond plasma biopsies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты